Home Search
pathology - search results
If you're not happy with the results, please do another search
Parkinson’s management: Living with the fastest-growing neurological condition in the world
We spoke with Parkinson’s UK, an organisation dedicated to funding important research and supporting those affected by Parkinson’s, about the prevalence, impact, and management of the condition.
The Importance of early cardiac screening for young people
Drawing on the charity’s work, Dr Steven Cox, Chief Executive of Cardiac Risk in the Young (CRY), explains why the UK Government must re-think its approach to specialist cardiac screening to reduce mortality among young people with conditions that can cause sudden cardiac death.
Dr Austen El-Osta – Imperial College London School of Public Health
I hold a Doctorate in Medicine from King’s College London, a Masters in Public Administration (MPA) from the London South Bank University, an MSc in Pathology & Virology from Imperial College London & a BSc in Molecular Biology & Genetics from Queen Mary University of London.
Moving past animal experiments to understand human neurological disease
Richard J. Miller, PhD, Professor Emeritus of Pharmacology at Northwestern University Feinberg School of Medicine, says that the belief monkeys and other animals are essential for performing translationally useful research for human neurological disease is outdated and incompatible with 21st-century science.
Blood test shows promise in identifying Alzheimer’s disease early
A £5 million project started in the UK last year aims to enable individuals to receive Alzheimer's diagnoses within seconds through the National Health Service (NHS) within the next five years.
Nutritional management of aging pets
Morgan A. Key from Hill’s Pet Nutrition outlines the changes associated with aging pets and how nutrition can help.
The long shadow of childhood mental health problems
Dr Niamh Dooley and Professor Mary Cannon explore what young adult life looks like for individuals who had mental health problems as children.
What is the link between white matter lesions and neurodegeneration?
Tara M. DeSilva from the Department of Neurosciences, Cleveland Clinic, examines the link between white matter lesions and neurodegeneration.
From byte to bedside: Ushering in the era of digital oncology to outsmart cancer
Philip Dunne and Mark Lawler from the Patrick G Johnston Centre for Cancer Research talk to us about the emerging field of ‘digital oncology’ and how their approach can truly optimise cancer research and care.
Herantis Pharma: Disease-modifying therapies for Parkinson’s disease
Herantis Pharma is an innovative biotech company developing disease-modifying therapies for Parkinson’s disease.
Controlling ovarian cancer: An introduction to detection and treatment
With current strategies proving inadequate, what needs to be done is to further the research into detecting, treating, and controlling ovarian cancer.
AI to diagnose Parkinsons: A groundbreaking paradigm shift
In a groundbreaking collaboration, the Accelerated Capability Environment (ACE) has teamed up with the NHS's AI Skunkworks to harness AI to diagnose Parkinsons with unprecedented speed.
Hani N. Sabbah – Henry Ford Hospital
Dr. Hani N. Sabbah is the Director of Cardiovascular Research at Henry Ford Health, Professor of Medicine at Wayne State University, and Professor of Medicine Research at Michigan State University
He received a Bachelor of Science in aerospace engineering from University of Oklahoma and Doctorate in Biomedical Sciences and Medical...
Understanding soil and its crucial role to life with the Department of Agroecology
The Department of Agroecology at Aarhus University is an internationally recognized research institution dealing with agro-ecosystems and creates, develops and translates cutting-edge knowledge to advance the bioeconomy of the community, both in Denmark and abroad.
Lecanemab and other treatments: Glimmers of hope for alzheimer’s patients
Effective treatments for amyloid-associated neurological diseases are desperately needed; H. Robert Guy, CEO of Amyloid Research Consultants, talks us through the obstacles and opportunities associated with structure-based drug design.
Breakthrough blood test to detect Alzheimer’s disease
A new groundbreaking blood test, p-tau217, holds potential as an Alzheimer's disease indicator. When incorporated into a two-step process, it demonstrates exceptional accuracy in detecting or ruling out brain amyloidosis, a crucial early sign.
How can AI oncology diagnostics help the NHS?
DeepMed has developed an AI oncology diagnostics system, DeepPathTM - LYDIA, to assist histopathologists in performing lymph node metastasis detection quickly and accurately.
Magnetic and acoustic levitation to protect bioprint heart models against radiation
The new PULSE project utilising both magnetic and acoustic levitation claims to hold the key to bioprinting technology with potential applications in space and on Earth.
What is the Psychedelic Renaissance and what can we learn from its history
Psychedelic therapies are breathing optimism back into modern psychiatry. Substances like psilocybin mushrooms, MDMA, and ketamine are showing clinical promise in a number of treatment-resistant categories of mental disorders, and we are beginning to see a psychedelic renaissance.
Channakeshava S Umeshappa – Dalhousie University
Dr. Umeshappa completed his Doctor of Veterinary Medicine degree at Karnataka Veterinary, Animal and Fisheries Sciences University, India
He received a Master of Veterinary Science degree in Veterinary Pathology from the Indian Veterinary Research Institute, India, where he studied the immunopathology of Bluetongue (BT), an arboviral disease of sheep, and...